Biotics Research has developed a proprietary delivery system of utilising microemulsified cholecalciferol (vitamin D3) for enhanced absorption. It is absorbed into the lymph system before the first liver pass.

People not sufficiently exposed to the sun do not synthesise adequate vitamin D in order to meet physiological requirements.

While vitamin D is synergistic to both calcium and magnesium, and the importance it plays in neuro-musculoskeletal functioning has long been recognised, modern research is finding that vitamin D deficiency plays an important role in a wide variety of processes. This includes but are not limited to cardiovascular, immune, and psychological functioning.

The discovery of vitamin D receptors in tissues other than the gut and bone – particularly the brain, breast, prostate, and lymphocytes – has led recent researchers to suggest the utilisation of higher amounts of supplemental vitamin D for a wider range of applications in order to maintain and improve patient health.

Evidence suggests that vitamin D deficiency is particularly common among patients with inflammatory and autoimmune disorders and that vitamin D can modulate inflammatory responses.

Biotics Research has developed a proprietary delivery system of utilising microemulsified cholecalciferol (vitamin D3) for enhanced absorption, which can be especially important with patients with malabsorption issues.

Serving Instructions

One (1) drop each day as a dietary supplement or as otherwise directed by a healthcare professional.

Serving Size

1 drop (0.04 ml) contains:

Ingredients

Vitamin D3 (as cholecalciferol) 10 µg (400iu)

Other Ingredients

Water
Gum Arabic
Sesame Oil